ECSP034852A - Moduladores de receptores ampa alostéricos naftotiazina-positivos (paarm) - Google Patents

Moduladores de receptores ampa alostéricos naftotiazina-positivos (paarm)

Info

Publication number
ECSP034852A
ECSP034852A EC2003004852A ECSP034852A ECSP034852A EC SP034852 A ECSP034852 A EC SP034852A EC 2003004852 A EC2003004852 A EC 2003004852A EC SP034852 A ECSP034852 A EC SP034852A EC SP034852 A ECSP034852 A EC SP034852A
Authority
EC
Ecuador
Prior art keywords
ampa
paarm
naftotiazine
alosteric
receptors modulators
Prior art date
Application number
EC2003004852A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Weiser
Angelo Ceci
Klaus Klinder
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034852A publication Critical patent/ECSP034852A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
EC2003004852A 2001-05-17 2003-11-17 Moduladores de receptores ampa alostéricos naftotiazina-positivos (paarm) ECSP034852A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10123952A DE10123952A1 (de) 2001-05-17 2001-05-17 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
ECSP034852A true ECSP034852A (es) 2003-12-24

Family

ID=7685080

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004852A ECSP034852A (es) 2001-05-17 2003-11-17 Moduladores de receptores ampa alostéricos naftotiazina-positivos (paarm)

Country Status (26)

Country Link
EP (1) EP1404340A1 (pt)
JP (1) JP2004529980A (pt)
KR (1) KR20040007572A (pt)
CN (1) CN1533278A (pt)
AR (1) AR036332A1 (pt)
BG (1) BG108324A (pt)
BR (1) BR0209796A (pt)
CA (1) CA2449189A1 (pt)
CO (1) CO5550460A2 (pt)
CZ (1) CZ20033112A3 (pt)
DE (1) DE10123952A1 (pt)
EA (1) EA006608B1 (pt)
EC (1) ECSP034852A (pt)
EE (1) EE200300566A (pt)
HR (1) HRP20030933A2 (pt)
HU (1) HUP0401273A3 (pt)
IL (1) IL158642A0 (pt)
MX (1) MXPA03010373A (pt)
NO (1) NO20035088L (pt)
NZ (1) NZ530154A (pt)
PL (1) PL364053A1 (pt)
SK (1) SK14222003A3 (pt)
UY (1) UY27290A1 (pt)
WO (1) WO2002100411A1 (pt)
YU (1) YU90403A (pt)
ZA (1) ZA200308466B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090047534A (ko) * 2006-08-31 2009-05-12 더 거버너스 오브 더 유니버시티 오브 앨버타 양성 알로스테릭 ampa 수용체 조절인자를 사용하여 호흡 저하를 억제하는 방법
CN111518058B (zh) * 2020-05-29 2021-03-09 四川大学华西医院 一种噁噻嗪类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
JP2002518498A (ja) * 1998-06-25 2002-06-25 メルク エンド カムパニー インコーポレーテッド ナフト[1,8−de]チアジン−2−イルメチルカルバペネム抗菌物質
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CN1533278A (zh) 2004-09-29
SK14222003A3 (sk) 2004-05-04
AR036332A1 (es) 2004-09-01
NZ530154A (en) 2005-09-30
ZA200308466B (en) 2004-05-24
MXPA03010373A (es) 2004-03-16
CZ20033112A3 (en) 2004-03-17
CO5550460A2 (es) 2005-08-31
BG108324A (bg) 2004-12-30
HUP0401273A2 (hu) 2004-10-28
IL158642A0 (en) 2004-05-12
CA2449189A1 (en) 2002-12-19
KR20040007572A (ko) 2004-01-24
HRP20030933A2 (en) 2004-04-30
PL364053A1 (en) 2004-12-13
JP2004529980A (ja) 2004-09-30
NO20035088D0 (no) 2003-11-14
NO20035088L (no) 2003-11-14
UY27290A1 (es) 2002-12-31
EA200301167A1 (ru) 2004-06-24
BR0209796A (pt) 2004-06-01
EP1404340A1 (en) 2004-04-07
DE10123952A1 (de) 2002-11-21
EE200300566A (et) 2004-02-16
WO2002100411A1 (en) 2002-12-19
HUP0401273A3 (en) 2006-11-28
EA006608B1 (ru) 2006-02-24
YU90403A (sh) 2006-05-25

Similar Documents

Publication Publication Date Title
BRPI0411528A (pt) uso de isomalte como prebiótico
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
ECSP066667A (es) Derivados de ciclohexano espirociclicos
SV2008002986A (es) Moduladores de indol sulfonamida de receptores de progesterona ref. x-17207
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
UY31524A1 (es) Nuevos compuestos 010
ECSP099394A (es) Derivados de quinuclidinol como antogonistas de receptores muscarínicos
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
UY27629A1 (es) Nuevos anticolinérgicos, procedimiento para su preparación , así como su uso como medicamentos
AR057325A1 (es) Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
UY30206A1 (es) Derivados de diamina, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
NI200700056A (es) Nuevos derivados de sulfamidas de heteroaril benzo-fundido útiles como agentes anticonvulsivos
ECSP066948A (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
AR029210A1 (es) DERIVADOS DE N-(5-SULFAMOIL-1,3-TIAZOL-2-IL) ACETAMIDA, PROCEDIMIENTO PARA SU PREPARACIoN, COMPUESTOS INTERMEDIARIOS, COMPOSICIoN FARMACÉUTICA, Y EL USO DE DICHOS DERIVADOS PARA LA PRODUCCIoN DE MEDICAMENTOS
UY28144A1 (es) Agentes terapéuticos
UY27109A1 (es) Derivados de quinazolona como antagonistas de receptores adrenergicos alfa-1a/b
UY27851A1 (es) Difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
UY29768A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
AR054508A1 (es) Compuesto de bencilpiperazina, su uso para preparar un medicamento, procedimientos para la preparacion de dicho compuesto y de compuestos intermediarios, dichos compuestos intermediarios, composicion farmaceutica que lo comprende y procedimiento para prepararla
UY28694A1 (es) Nuevos compuestos
UY27263A1 (es) Nuevas arilsulfonamidas como agentes antivirales
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones